2025-02-17 - 🧬 [nGram] Oncology Highlights (11th Feb - 17th Feb): Lion TCR's FDA Clearance, Pfizer's ADCETRIS® Approval, Bayer's Prostate Data

2025-02-10 - 🧬 [nGram] Oncology Highlights (4th Feb - 10th Feb): Serplulimab EU Approval, RedHill & MAIA Trials, Gradalis RMAT

2025-02-03 - 🧬 [nGram] Oncology Highlights (28th Jan - 3rd Feb): Taiho & Cullinan's NSCLC Trial Success, ITM's GEP-NETs Results, Roche's Breast Cancer Breakthrough

2025-01-27 - 🧬 [nGram] Oncology Highlights (21st Jan - 27th Jan): EC Approves LAZCLUZE, Replimune's Priority Review, Sarclisa EU Approval

2025-01-20 - 🧬 [nGram] Oncology Highlights (14th Jan - 20th Jan): HUTCHMED's ORPATHYS® Approval, Ariceum's FDA Clearance, Umoja's $100M Series C

2025-01-13 - 🧬 [nGram] Oncology Highlights (7th Jan - 13th Jan): Immuneering's Pancreatic Cancer Trial, RYBREVANT® Combo Success, FDA Priority Review for Sunvozertinib

2025-01-06 - 🧬 [nGram] Oncology Highlights (31st Dec - 6th Jan): CARsgen Trial, Galera Acquisition, Innovent & Roche Deal

2024-12-30 - 🧬 [nGram] Oncology Highlights (24th Dec - 30th Dec): AstraZeneca Acquires Assets, Opdivo Qvantig™ Approved, EU Lung Cancer Update

2024-12-23 - 🧬 [nGram] Oncology Highlights (17th Dec - 23rd Dec): FDA Breakthrough for Trodelvy, J&J EMA Application, Affimed NSCLC Update

2024-12-16 - 🧬 [nGram] Oncology Highlights (10th Dec - 16th Dec): CARVYKTI® & IMUNON Lead Breakthroughs

2024-12-09 - 🧬 [nGram] Oncology Highlights (3rd Dec - 9th Dec): FDA Breakthroughs, Licensing Deals & Clinical Trials

2024-12-02 - 🧬 [nGram] Oncology Highlights (26th Nov - 2nd Dec): Roche Acquires Poseida, BeiGene's TEVIMBRA Approved, Dr. Reddy's Launches Toripalimab

2024-11-25 - 🧬 [nGram] Oncology Highlights (19th Nov - 25th Nov): Jazz Pharma's Ziihera® FDA Approval, Alpha Biopharma's Zorifer® NMPA Approval, & More

2024-11-18 - 🧬 [nGram] Oncology Highlights (12th Nov - 18th Nov): Datopotamab Deruxtecan BLA, Wugen CAR-T Trial, Pimicotinib Phase III

2024-11-04 - 🧬 [nGram] Oncology Highlights (29th Oct - 4th Nov): Novartis Scemblix® FDA Approval, Genentech's Landmark Results, Allogene RMAT Designation

2024-10-31 - 🧬 [nGram] Oncology Highlights (25th Oct - 31st Oct): IDEAYA, Merck & Moderna, Trinity Biotech, Celldex

2024-10-28 - 🧬 [nGram] Oncology Highlights (22nd Oct - 28th Oct): FDA Approvals, BriaCell's Breakthrough, AvenCell's $112M Series B

2024-10-24 - 🧬 [nGram] Oncology Highlights (18th Oct - 24th Oct): Novartis' Kisqali® CHMP Nod, Evergreen's EU Trial, Nurix's Positive Results

2024-10-22 - 🧬 [nGram] Oncology Highlights (16th Oct - 22nd Oct): TAGRISSO® & ORPATHYS® Lung Cancer Breakthrough, Cadonilimab Cervical Cancer Success

2024-10-18 - 🧬 [nGram] Today’s Oncology Scoop: Novo Nordisk's Alhemo®, Novartis' Kisqali®, Sanofi's Radioligand Collaboration

2024-10-10 - 🧬 [nGram] Today’s Oncology Scoop: J&J's DARZALEX® EMA Submission, Immatics & Oncoinvent Updates

2024-10-09 - 🧬 [nGram] Today’s Oncology Scoop: Antag's IND Clearance, Leads' Breakthrough, Clearside's Positive Results

2024-10-08 - 🧬 [nGram] Today’s Oncology Scoop: Merck's KEYTRUDA® EFS Success, Ultragenyx Breakthrough, Boehringer's MASH Trials

2024-10-07 - 🧬 [nGram] Today’s Oncology Scoop: Clasp's T Cell Engager & HPV Vaccine Trial

2024-10-04 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approvals & Key Cancer Trials

2024-10-03 - 🧬 [nGram] Today’s Oncology Scoop: UGN-103 Trial, Gilead's HIV Initiative, Enara Bio Funding

2024-10-02 - 🧬 [nGram] Today’s Oncology Scoop: ENHERTU® Priority Review, Owkin & AstraZeneca AI Partnership, Volastra FDA Fast Track

2024-10-01 - 🧬 [nGram] Today’s Oncology Scoop: ENHERTU® Priority Review, Merus Phase 3 Trial, Perjeta® Biosimilar Success

2024-09-30 - 🧬 [nGram] Today’s Oncology Scoop: Genentech Acquires Regor's CDK Inhibitors, Enliven's Positive Phase 1 Data, Estrella's Complete Response

2024-09-27 - 🧬 [nGram] Today’s Oncology Scoop: TAGRISSO® Approval, Tempus & Takeda Collaboration, BeiGene FDA Update

2024-09-26 - 🧬 [nGram] Today’s Oncology Scoop: Merck’s KEYTRUDA® New Approvals, Bayer’s Darolutamide Application, BioAge Labs IPO

2024-09-25 - 🧬 [nGram] Today’s Oncology Scoop: Takeda's FRUZAQLA Approval, Junshi's Toripalimab in EU, Silexion's Phase 2 Data

2024-09-24 - 🧬 [nGram] Today’s Oncology Scoop: Takeda's FRUZAQLA Approval, Datopotamab Deruxtecan Results, PADCEV & KEYTRUDA Approval

2024-09-23 - 🧬 [nGram] Today’s Oncology Scoop: BioCity's BC3195 at ESMO, Merck's KEYTRUDA, IDEAYA's Darovasertib

2024-09-20 - 🧬 [nGram] Today’s Oncology Scoop: Neu-REFIX Beta Glucan, Narmafotinib, Edgewise Therapeutics, Tolebrutinib

2024-09-19 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approves Merck’s KEYTRUDA, ESMO 2024 Highlights, Brenus Pharma Raises $25M

2024-09-18 - 🧬 [nGram] Today’s Oncology Scoop: Merck’s KEYTRUDA® Approval, ImCheck’s Fast Track, Brenus Pharma Funding

2024-09-17 - 🧬 [nGram] Today’s Oncology Scoop: ESMO 2024 Highlights, FDA Guidance, and Breakthrough Trials

2024-09-16 - 🧬 [nGram] Today’s Oncology Scoop: RYBREVANT® & KEYTRUDA® Show Promising Results

2024-09-13 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approves Roche’s Tecentriq Hybreza, Marengo & Gilead Collaboration, Bicara IPO

2024-09-12 - 🧬 [nGram] Today’s Oncology Scoop: Sanofi's Radioligand Deal, Aura's Phase 2 Success, PIONeeR at ESMO

2024-09-11 - 🧬 [nGram] Today’s Oncology Scoop: Pfizer at ESMO, Viridian & REVEAL Genomics Results

2024-09-10 - 🧬 [nGram] Today’s Oncology Scoop: OSE Immunotherapeutics Launches Phase 3 Study, Innovent's Phase 2 Results, ORYZON's Phase Ib Study

2024-09-09 - 🧬 [nGram] Today’s Oncology Scoop: Ivonescimab vs Pembrolizumab, Novocure's TTFields, Natera's Signatera™

2024-09-06 - 🧬 [nGram] Today’s Oncology Scoop: Abdera's FDA Orphan Drug, Akeso & Gilead at ESMO 2024

2024-09-05 - 🧬 [nGram] Today’s Oncology Scoop: ALX Oncology Doses First Patients, Merck's New Trials, Synthekine's FDA Fast Track

2024-09-04 - 🧬 [nGram] Today’s Oncology Scoop: Merck at ESMO, Pancreatic Cancer Trial, Cogent Biosciences Phase 3

2024-09-03 - 🧬 [nGram] Today’s Oncology Scoop: Merck’s KEYTRUDA® Approval, HighField’s IND Filing, Simcere Zaiming Collaboration

2024-08-30 - 🧬 [nGram] Today’s Oncology Scoop: Bayer's NSCLC Trial, Noetik's $40M Series A, and More

2024-08-29 - 🧬 [nGram] Today’s Oncology Scoop: Merck Trials, CancerVax Nanotech, Innovent at WCLC & ESMO

2024-08-28 - 🧬 [nGram] Today’s Oncology Scoop: FDA Priority Review for SpringWorks, EC Approves Astellas' PADCEV, Telix Submits NDA

2024-08-27 - 🧬 [nGram] Today’s Oncology Scoop: LIXTE’s LB-100 Trial, RYBREVANT® Approval, RedHill's Orphan Drug

2024-08-26 - 🧬 [nGram] Today’s Oncology Scoop: Galapagos FDA Clearance, GI Innovation & KEYTRUDA, Opna Bio Doses First Patient

2024-08-21 - 🧬 [nGram] Today’s Oncology Scoop: Exact Sciences MCED Study, BerGenBio & Tempus Collaboration, Inocras-Broad Institute Agreement

2024-08-20 - 🧬 [nGram] Today’s Oncology Scoop: RYBREVANT® & LAZCLUZE™ Approval, MOMA-313 Phase 1, ENHERTU® EMA Validation

2024-08-19 - 🧬 [nGram] Today’s Oncology Scoop: PT217 Orphan Drug Designation, MMRF CoMMpass Study

2024-08-16 - 🧬 [nGram] Today’s Oncology Scoop: Nuntius & Taiho mRNA Collaboration, New Hope for Neuroblastoma, Esopredict Study Results

2024-08-15 - 🧬 [nGram] Today’s Oncology Scoop: IMFINZI® Priority Review, Niktimvo™ FDA Approval, Positive Clinical Updates

2024-08-14 - 🧬 [nGram] Today’s Oncology Scoop: PanTher's FDA Clearance, Viracta's Positive Data, Financial Updates

2024-08-13 - 🧬 [nGram] Today’s Oncology Scoop: Biosyngen's FDA Approval, Junshi's New Drug Application, Citius Merger

2024-08-12 - 🧬 [nGram] Today’s Oncology Scoop: Halda Therapeutics Secures $126M, Kiromic BioPharma Trial Update

2024-08-09 - 🧬 [nGram] Today’s Oncology Scoop: Merck Acquires CN201, Abzena Supplies AGX101, Q2 Financial Results

2024-08-08 - 🧬 [nGram] Today’s Oncology Scoop: Merck's KeyVibe-008, Citius FDA Approval, WestGene's Dual INDs

2024-08-07 - 🧬 [nGram] Today’s Oncology Scoop: Exelixis FDA Update, Daiichi Sankyo & Merck Deal, IDRx Financing

2024-08-06 - 🧬 [nGram] Today’s Oncology Scoop: Elevation, Lantern, SEED, Galvanize & More

2024-08-05 - 🧬 [nGram] Today’s Oncology Scoop: Adaptimmune's FDA Approval, Gene Therapy for Synovial Sarcoma, Galapagos Trial Pause

2024-08-02 - 🧬 [nGram] Today’s Oncology Scoop: Adaptimmune's TECELRA® FDA Approval, Jemperli Expanded Use, New Trials & More

2024-08-01 - 🧬 [nGram] Today’s Oncology Scoop: ALX Oncology's Phase 2 Success, Immuneering's FDA Fast Track, OS Therapies IPO

2024-07-31 - 🧬 [nGram] Today’s Oncology Scoop: IMUNON's Ovarian Cancer Breakthrough, Umoja's FDA Clearance, DARZALEX FASPRO® Approval

2024-07-30 - 🧬 [nGram] Today’s Oncology Scoop: BioNTech's Phase 2 Success, IMUNON's Upcoming Results, Verastem's FDA Orphan Drug Status

2024-07-29 - 🧬 [nGram] Today’s Oncology Scoop: CHMP Recommends RYBREVANT®, CStone's Sugemalimab Approved, Immorta Bio's SenoVax™ IND

2024-07-26 - 🧬 [nGram] Today’s Oncology Scoop: FDA Grants Orphan Drug Status to Cellectis’ UCART22, Summit & MD Anderson Collaboration, Presage Biosciences Doses First Patient

2024-07-25 - 🧬 [nGram] Today’s Oncology Scoop: Inimmune Doses First Patient, Novartis Collaboration, Notable Labs FDA Clearance

2024-07-24 - 🧬 [nGram] Today’s Oncology Scoop: AffyImmune RMAT, BioAtla Fast Track, Anixa IND

2024-07-23 - 🧬 [nGram] Today’s Oncology Scoop: Immutep's FDA Success, BeiGene's New Facility, and More

2024-07-22 - 🧬 [nGram] Today’s Oncology Scoop: Nuvalent Doses First Patient, Zymeworks FDA Clearance, TME Pharma Strategy

2024-07-19 - 🧬 [nGram] Today’s Oncology Scoop: Bristol Myers Squibb's Opdivo, AVEO's Phase 3 Results, Deciphera's EMA Application

2024-07-18 - 🧬 [nGram] Today’s Oncology Scoop: Junshi's New Drug Application & Biotheryx's Phase 1 Trial

2024-07-17 - 🧬 [nGram] Today’s Oncology Scoop: Bayer's NUBEQA® Phase III Success, FDA Orphan Drug Designations

2024-07-16 - 🧬 [nGram] Today’s Oncology Scoop: Biosyngen's BRG01 Phase II, Mabwell's NMPA Approval, GRAIL's Galleri® Trial

2024-07-12 - 🧬 [nGram] Today’s Oncology Scoop: Senhwa IND, Revolution Medicines, KOLON Phase III

2024-07-11 - 🧬 [nGram] Today’s Oncology Scoop: Rgenta's IND Clearance, Kazia's Phase II/III Results, Can-Fite's Orphan Drug Application

2024-07-10 - 🧬 [nGram] Today’s Oncology Scoop: Obsidian's FDA Fast Track, Curium's NDA, Prelude & Merck Collaboration

2024-07-09 - 🧬 [nGram] Today’s Oncology Scoop: SELLAS Orphan Drug, iOnctura NSCLC Trial, Radionetics-Lilly Deal

2024-07-08 - 🧬 [nGram] Today’s Oncology Scoop: Immorna, IDEAYA, Hinova, Biostar, iTeos, Myricx, XPOVIO, Olverembatinib, IASO

2024-07-05 - 🧬 [nGram] Today’s Oncology Scoop: Breakthrough in Breast Cancer Treatment, New Drug Approval, and More

2024-07-04 - 🧬 [nGram] Today’s Oncology Scoop: Roche's SKYSCRAPER-06 Update, Boehringer's SIRP Treatment, HUTCHMED's NDA

2024-07-03 - 🧬 [nGram] Today’s Oncology Scoop: Legend Biotech's CARTITUDE-4, Biogen's Acquisition, Full-Life's FDA Fast Track

2024-07-02 - 🧬 [nGram] Today’s Oncology Scoop: Allogene's Phase 2 Trial, Ipsen's Cabometyx Expansion, Orion & MSD's Opevesostat Deal

2024-07-01 - 🧬 [nGram] Today’s Oncology Scoop: BALVERSA® & RYBREVANT® Get EU Nod, SCG Cell Therapy FDA IND Clearance

2024-06-28 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approvals, New Data, and Clinical Trial Updates

2024-06-27 - 🧬 [nGram] Today’s Oncology Scoop: EPKINLY® FDA Approval, GenVivo Trial, Cancer Drug Shortage

2024-06-26 - 🧬 [nGram] Today’s Oncology Scoop: Lyell's CAR-T, Simcere's Cetuximab, Junshi's Toripalimab

2024-06-25 - 🧬 [nGram] Today’s Oncology Scoop: IMFINZI® Success, Oncoinvent Fast Track, Merck KGaA Update

2024-06-24 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approvals, Clinical Updates & More

2024-06-21 - 🧬 [nGram] Today’s Oncology Scoop: Allogene's Phase 2 Trial, Oncolytics' New Study, Tempest's Survival Data

2024-06-20 - 🧬 [nGram] Today’s Oncology Scoop: Basilea Partners with Glioblastoma Foundation, iOnctura Secures EUR80M

2024-06-19 - 🧬 [nGram] Today’s Oncology Scoop: GenFleet's IND Approval, Golidocitinib's New Approval, Medivir's Phase 2b Study, Aethlon's Ethics Approval

2024-06-18 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approves Merck’s KEYTRUDA, Junshi's sNDA for Toripalimab, Evaxion's 67% Response Rate

2024-06-17 - 🧬 [nGram] Today’s Oncology Scoop: IMFINZI® Approval, Roche’s Columvi Success, BLINCYTO® FDA Nod

2024-06-14 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approves Augtyro™, ASCO 2024 Highlights, and More

2024-06-13 - 🧬 [nGram] Today’s Oncology Scoop: MSK's Pancreatic Cancer Breakthrough, Innovent's FDA Fast Track, Immorta Bio's Lung Cancer Success

2024-06-12 - 🧬 [nGram] Today’s Oncology Scoop: City of Hope CAR T Cell Therapy, Junshi Biosciences Phase 3 Success, OBI Pharma's New Study

2024-06-11 - 🧬 [nGram] Today’s Oncology Scoop: FDA Clears Lomonitinib, SL-172154 Orphan Drug, Ultimovacs Phase I Update

2024-06-10 - 🧬 [nGram] Today’s Oncology Scoop: Roche’s Alecensa Approved, TAGRISSO® Priority Review, Zymeworks in China

2024-06-07 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approves Geron's RYTELO™, AbbVie's Positive Phase 2 Results, and More

2024-06-06 - 🧬 [nGram] Today’s Oncology Scoop: BridgeBio Doses First Patient, AbbVie Starts Ph. 3 Trial, Replimune Positive Data

2024-06-05 - 🧬 [nGram] Today’s Oncology Scoop: Bristol Myers Squibb's Opdivo/Yervoy Success, Pierre Fabre's IND Filing, MAIA's THIO Efficacy

Newsletters

neurology

business_development

oncology

Charts